KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Maxlinear (MXL) EBT (2016 - 2026)

Maxlinear has reported EBT over the past 17 years, most recently at -$18.7 million for Q1 2026.

  • Quarterly EBT rose 61.94% to -$18.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$110.5 million through Mar 2026, up 48.26% year-over-year, with the annual reading at -$140.9 million for FY2025, 40.98% up from the prior year.
  • EBT was -$18.7 million for Q1 2026 at Maxlinear, down from -$17.8 million in the prior quarter.
  • Over five years, EBT peaked at $45.0 million in Q1 2022 and troughed at -$82.5 million in Q3 2024.
  • The 5-year median for EBT is -$30.7 million (2025), against an average of -$16.9 million.
  • Year-over-year, EBT soared 703.12% in 2022 and then crashed 768.19% in 2024.
  • A 5-year view of EBT shows it stood at $40.7 million in 2022, then tumbled by 204.71% to -$42.6 million in 2023, then increased by 4.24% to -$40.8 million in 2024, then surged by 56.39% to -$17.8 million in 2025, then dropped by 4.77% to -$18.7 million in 2026.
  • Per Business Quant, the three most recent readings for MXL's EBT are -$18.7 million (Q1 2026), -$17.8 million (Q4 2025), and -$43.4 million (Q3 2025).